Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3

Watchlist Manager
Dimed SA Distribuidora de Medicamentos Logo
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Watchlist
Price: 9.58 BRL 0.31% Market Closed
Market Cap: 1.4B BRL
Have any thoughts about
Dimed SA Distribuidora de Medicamentos?
Write Note

Dimed SA Distribuidora de Medicamentos
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dimed SA Distribuidora de Medicamentos
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Gross Profit
R$1.5B
CAGR 3-Years
17%
CAGR 5-Years
12%
CAGR 10-Years
14%
Raia Drogasil SA
BOVESPA:RADL3
Gross Profit
R$11.2B
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
19%
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
Gross Profit
R$3.5B
CAGR 3-Years
19%
CAGR 5-Years
11%
CAGR 10-Years
N/A
d
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
Gross Profit
R$552.8m
CAGR 3-Years
19%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Dimed SA Distribuidora de Medicamentos
Glance View

Market Cap
1.4B BRL
Industry
Retail

Dimed SA Distribuidora de Medicamentos engages in the marketing, distribution and sale of medicines and cosmetics. The company is headquartered in Eldorado Do Sul, Rio Grande Do Sul and currently employs 9,414 full-time employees. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. The company organizes its business into two main segments: Medicine and Perfumery. The firm provides retail and wholesale distribution. The firm owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.

PNVL3 Intrinsic Value
16.71 BRL
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Dimed SA Distribuidora de Medicamentos's Gross Profit?
Gross Profit
1.5B BRL

Based on the financial report for Jun 30, 2024, Dimed SA Distribuidora de Medicamentos's Gross Profit amounts to 1.5B BRL.

What is Dimed SA Distribuidora de Medicamentos's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%

Over the last year, the Gross Profit growth was 13%. The average annual Gross Profit growth rates for Dimed SA Distribuidora de Medicamentos have been 17% over the past three years , 12% over the past five years , and 14% over the past ten years .

Back to Top